Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Femia, Angelo P ^a   Luceri, Cristina ^a   Toti, Simona ^a   Giannini, Augusto ^b   Dolara, Piero ^a   Caderni, Giovanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b General Hospital of Prato Azienda Sanitaria Locale 4   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; APC PROTEIN; CALGRANULIN A; CALGRANULIN B; CARRIER PROTEIN; DEFENSIN; DEFENSIN RELATED CRYPTDIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MUCIN 2; MUCOSAL PENTRAXIN; PENTRAXIN; RESISTIN; RESISTIN LIKE ALPHA; SOLUTE CARRIER FAMILY 26 MEMBER 3; SOMATOMEDIN BINDING PROTEIN 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CHROMOSOME 18; CHROMOSOME DELETION; CITRIC ACID CYCLE; COLON CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID OXIDATION; FISCHER 344 RAT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SELECTION; GENETIC VARIABILITY; GENOME ANALYSIS; MALE; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS REGULATION; QUANTITATIVE ANALYSIS; RAT; RESPIRATORY CHAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; ANIMAL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; COLON TUMOR; DNA MICROARRAY; GENE REGULATORY NETWORK; GENETICS; IMMUNOHISTOCHEMISTRY; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY;

1,2-DIMETHYLHYDRAZINE; ADENOCARCINOMA; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; IMMUNOHISTOCHEMISTRY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77951946768     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-194     Document Type: Article

References (58)

1. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009, 18:1688-94. 10.1158/1055-9965.EPI-09-0090, 19505900.
2. Femia AP, Caderni G. Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products. Planta Med 2008, 74:1602-7. 10.1055/s-2008-1074577, 18604780.
3. Corpet DE, Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur J Cancer 2005, 4:1911-22.
4. Cardoso J, Boer J, Morreau H, Fodde R. Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta 2007, 1775:103-37.
5. Nambiar PR, Nakanishi M, Gupta R, Cheung E, Firouzi A, Ma XJ, Flynn C, Dong M, Guda K, Levine J, Raja R, Achenie L, Rosenberg DW. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Res 2004, 64:6394-401. 10.1158/0008-5472.CAN-04-0933, 15374946.
6. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, Doetschman T, Groden J, Dove WF, Threadgill DW, Yeatman TJ, Coffey RJ, Aronow BJ. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumour models and human colon cancer. Genome Biol 2007, 8:R131. 10.1186/gb-2007-8-7-r131, 2323222, 17615082.
7. Luceri C, De Filippo C, Caderni G, Gambacciani L, Salvadori M, Giannini A, Dolara P. Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumours by random amplified polymorphic DNA analysis. Carcinogenesis 2000, 21:1753-6. 10.1093/carcin/21.9.1753, 10964108.
8. Guda K, Upender MB, Belinsky G, Flynn C, Nakanishi M, Marino JN, Ried T, Rosenberg DW. Carcinogen-induced colon tumours in mice are chromosomally stable and are characterized by low-level microsatellite instability. Oncogene 2004, 23:3813-21. 10.1038/sj.onc.1207489, 15021908.
9. Femia AP, Caderni G, Bottini C, Salvadori M, Dolara P, Tessitore L. Mucin-depleted foci are modulated by dietary treatments and show deregulation of proliferative activity in carcinogen-treated rodents. Int J Cancer 2007, 120:2301-5. 10.1002/ijc.22145, 17294441.
10. European Community European community regulations on the care and use of laboratory animals. Law 86/609/EC 1986, European Community.
11. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. Antitumourigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002, 23:1953-60. 10.1093/carcin/23.11.1953, 12419846.
12. Lodovici M, Luceri C, De Filippo C, Romualdi C, Bambi F, Dolara P. Smokers and passive smokers gene expression profiles: correlation with the DNA oxidation damage. Free Radic Biol Med 2007, 43:415-22. 10.1016/j.freeradbiomed.2007.04.018, 17602957.
13. Castagnini C, Luceri C, Toti S, Bigagli E, Caderni G, Femia AP, Giovannelli L, Lodovici M, Pitozzi V, Salvadori M, Messerini L, Martin R, Zoetendal EG, Gaj S, Eijssen L, Evelo CT, Renard CM, Baron A, Dolara P. Reduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Ménard apples, rich in polyphenols. Br J Nutr 2009, 22:1-9.
14. Smyth GK. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Statistical Applications in Genetics and Molecular Biology 2004, 3(1). Article 3, 10.2202/1544-6115.1027, 16646809.
15. Gene Map Annotator and Pathway Profiler Version 2.1. , http://www.genmapp.org
16. Luceri C, Caderni G, Sanna A, Dolara P. Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced F344 rat colon tumours. J Nutr 2002, 132:1376-9.
17. Van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, Hatzis P, Thiele A, Born M, Begthel H, Brabletz T, Taketo MM, Clevers H. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 2005, 7:381-6. 10.1038/ncb1240, 15778706.
18. Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2009, 71:241-60. 10.1146/annurev.physiol.010908.163145, 18808327.
19. Fujiwara K, Ochiai M, Ohta T, Ohki M, Aburatani H, Nagao M, Sugimura T, Nakagama H. Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis 2004, 25:1495-505. 10.1093/carcin/bgh155, 15059925.
20. Flier LG, Sabates-Bellver J, Oving I, Haegebarth A, De Palo M, Anti M, Van Gijn ME, Suijkerbuijk S, Wetering M, Marra G, Clevers H. The Intestinal Wnt/TCF Signature. Gastroenterology 2007, 132:628-32. 10.1053/j.gastro.2006.08.039, 17320548.
21. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23:101-17. 10.1023/A:1025867130437, 15000152.
22. Andreasen PA, Kjøller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997, 72:1-22. 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z, 9212216.
23. Kermorgant S, Aparicio T, Dessirier V, Lewin MJ, Lehy T. Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis 2001, 22:1035-42. 10.1093/carcin/22.7.1035, 11408346.
24. Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr 2004, 24:151-72. 10.1146/annurev.nutr.24.012003.132402, 15189117.
25. Song MK, Heng MC, Rolandelli R, Ament ME, Heng MK. Possible link between zinc intake and colon cancer. J Natl Cancer Inst 1993, 85:667-9. 10.1093/jnci/85.8.667, 8385712.
26. Seya T, Tanaka N, Shinji S, Yokoi K, Koizumi M, Teranishi N, Yamashita K, Tajiri T, Ishiwata T, Naito Z. Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis. Oncol Rep 2006, 16:1225-30.
27. Beattie J, Allan GJ, Lochrie JD, Flint DJ. Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J 2006, 395:1-19. 10.1042/BJ20060086, 1409685, 16526944.
28. Reichling T, Goss KH, Carson DJ, Holdcraft RW, Ley-Ebert C, Witte D, Aronow BJ, Groden J. Transcriptional profiles of intestinal tumours in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumours. Cancer Res 2005, 65:166-76.
29. Hemers E, Duval C, McCaig C, Handley M, Dockray GJ, Varro A. Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: implications for epithelial-mesenchymal signaling. Cancer Res 2005, 65:7363-9. 10.1158/0008-5472.CAN-05-0157, 16103088.
30. Rho SB, Dong SM, Kang S, Seo SS, Yoo CW, Lee DO, Woo JS, Park SY. Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumour suppressor by inhibiting angiogenesis. Carcinogenesis 2008, 29:2106-11. 10.1093/carcin/bgn206, 18775916.
31. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 2000, 21:1319-27. 10.1093/carcin/21.7.1319, 10874009.
32. Ohta T, Takahashi M, Ochiai A. Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers. Cancer Lett 2005, 239:246-53. 10.1016/j.canlet.2005.08.014, 16216410.
33. Femia AP, Dolara P, Luceri C, Salvadori M, Caderni G. Mucin-depleted foci show strong activation of inflammatory markers in 1,2-dimethylhydrazine-induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate. Int J Cancer 2009, 125:541-7. 10.1002/ijc.24417, 19431205.
34. Gebhardt C, Németh J, Angel P, Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006, 72:1622-31. 10.1016/j.bcp.2006.05.017, 16846592.
35. Stulík J, Osterreicher J, Koupilová K, Knízek, Macela A, Bures J, Jandík P, Langr F, Dedic K, Jungblut PR. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumour mass. Electrophoresis 1999, 20:1047-54. 10.1002/(SICI)1522-2683(19990101)20:4/5<1047::AID-ELPS1047>3.0.CO;2-E , 10344284.
36. Myung SJ, Rerko RM, Yan M, Platzer P, Guda K, Dotson A, Lawrence E, Dannenberg AJ, Lovgren AK, Luo G, Pretlow TP, Newman RA, Willis J, Dawson D, Markowitz SD. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumourigenesis. Proc Natl Acad Sci USA 2006, 103:12098-102. 10.1073/pnas.0603235103, 1567703, 16880406.
37. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumour angiogenesis and colon cancer progression. Cancer Res 1998, 58:334-41.
38. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2006, 5:997-1014. 10.1038/nrd2154, 17139285.
39. The Wnt Homepage: Wnt target genes. , http://www.stanford.edu/~rnusse/pathways/targets.html
40. Barker N, van Es JH, Kuipers J, Kujala P, Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-7. 10.1038/nature06196, 17934449.
41. McClanahan T, Koseoglu S, Smith K, Grein J, Gustafson E, Black S, Kirschmeier P, Samatar AA. Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumours. Cancer Biol Ther 2006, 5:419-26.
42. Biswas S, Chytil A, Washington K, Romero-Gallo J, Gorska AE, Wirth PS, Gautam S, Moses HL, Grady WM. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res 2004, 64:4687-92. 10.1158/0008-5472.CAN-03-3255, 15256431.
43. Muñoz NM, Upton M, Rojas A, Washington MK, Lin L, Chytil A, Sozmen EG, Madison BB, Pozzi A, Moon RT, Moses HL, Grady WM. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res 2006, 66:9837-44. 10.1158/0008-5472.CAN-06-0890, 17047044.
44. Biasi F, Mascia C, Poli G. The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of TGF-β1 signaling. Carcinogenesis 2008, 29:890-4. 10.1093/carcin/bgn106, 18453540.
45. Massagué J. TGF-β in Cancer. Cell 2008, 134:215-30. 10.1016/j.cell.2008.07.001, 18662538.
46. Bachman KE, Park BH. Duel nature of TGF-beta signaling: tumour suppressor vs. tumour promoter. Curr Opin Oncol 2005, 17:49-54. 10.1097/01.cco.0000143682.45316.ae, 15608513.
47. Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J. Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea. Nat Genet 1996, 14:316-9. 10.1038/ng1196-316, 8896562.
48. Schweinfest CW, Henderson KW, Suster S, Kondoh N, Papas TS. Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas. Proc Natl Acad Sci USA 1993, 90:4166-70. 10.1073/pnas.90.9.4166, 46467, 7683425.
49. Meer-Van Kraaij C, Van Lieshout EM, Kramer E, Meer R, Keijer J. Mucosal pentraxin (Mptx), a novel rat gene 10-fold down-regulated in colon by dietary heme. FASEB J 2003, 17:1277-85. 10.1096/fj.02-1036com, 12832292.
50. Munitz A, Seidu L, Cole ET, Ahrens R, Hogan SP, Rothenberg ME. Resistin-like molecule alpha decreases glucose tolerance during intestinal inflammation. J Immunol 2009, 182:2357-63. 10.4049/jimmunol.0803130, 2653277, 19201890.
51. Femia AP, Tarquini E, Salvadori M, Ferri S, Giannini A, Dolara P, Caderni G. K-ras mutations and mucin profile in preneoplastic lesions and colon tumours induced in rats by 1,2-dimethylhydrazine. Int J Cancer 2008, 122:117-23. 10.1002/ijc.23065, 17847023.
52. Mizoshita T, Tsukamoto T, Inada KI, Hirano N, Tajika M, Nakamura T, Ban H, Tatematsu M. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon. Histol Histopathol 2007, 22:251-60.
53. Ortega AD, Sánchez-Aragó M, Giner-Sánchez D, Sánchez-Cenizo L, Willers I, Cuezva JM. Glucose avidity of carcinomas. Cancer Lett 2009, 276:125-35. 10.1016/j.canlet.2008.08.007, 18790562.
54. Halberg RB, Waggoner J, Rasmussen K, White A, Clipson L, Prunuske AJ, Bacher JW, Sullivan R, Washington MK, Pitot HC, Petrini JH, Albertson DG, Dove WF. Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. Cancer Res 2009, 69:5768-75. 10.1158/0008-5472.CAN-09-0446, 19584276.
55. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW. APC mutations occur early during colorectal tumorigenesis. Nature 1992, 359:235-7. 10.1038/359235a0, 1528264.
56. Shibata H, Takano H, Ito M, Shioya H, Hirota M, Matsumoto H, Kakudo Y, Ishioka C, Akiyama T, Kanegae Y, Saito I, Noda T. Alpha-catenin is essential in intestinal adenoma formation. Proc Natl Acad Sci USA 2007, 104:18199-204. 10.1073/pnas.0705730104, 2084320, 17989230.
57. Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM, Mareel MM. Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells. Cancer Res 1995, 55:4722-8.
58. Raftopoulos I, Davaris P, Karatzas G, Karayannacos P, Kouraklis G. Level of alpha-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential, and survival. J Surg Oncol 1998, 68:92-9. 10.1002/(SICI)1096-9098(199806)68:2<92::AID-JSO4>3.0.CO;2-F, 9624037.